Erector Spinae Plane Block Impact on Quality of Recovery After Lumbar Spinal Decompression

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

November 1, 2021

Study Completion Date

December 15, 2021

Conditions
Postoperative Pain
Interventions
DRUG

Bupivacain

Patients will be placed in left lateral position. A low-frequency curved array ultrasound transducer will be used. The ultrasound transducer will be placed in a longitudinal orientation 2-3 cm lateral to the midline to identify the hyperechoic line of the transverse process. After identification of muscles superficial to the transverse process and local infiltration of anesthesia into the superficial tissues, a block needle will be inserted in a craniocaudal direction until contact will be achieved with the transverse process where the tip will lay in the interfascial plane below the erector spinae muscle. A small bolus of local anaesthetic should be given through the block needle; the erector spinae muscle should be visualized, separating from the transverse process. A total of 20 mL bupivacaine 0.25% will be injected into the interfacial plane deep to the erector spinae muscle bilaterally. Forty minutes after the ESPB, the cutaneous sensory block will be assessed.

Trial Locations (1)

13511

Banha Faculity of Medicine, Banhā

All Listed Sponsors
lead

Benha University

OTHER